Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality

Archives of Internal Medicine

Volumn 162, Issue 13, 2002, Pages 1472-1476

  Muntwyler, Jorg ^a   Hennekens, Charles H ^b   Manson, JoAnn E ^c,e   Buring, Julie E ^c,d,e   Michael Gaziano, J ^c,f  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; MULTIVITAMIN;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DEATH CERTIFICATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MORTALITY; OXIDATIVE STRESS; PHYSICIAN; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SECONDARY PREVENTION; VITAMIN SUPPLEMENTATION;

EID: 0037043262     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.13.1472     Document Type: Article

References (39)

1. Lipoprotein oxidation and lipoprotein-induced cytotoxicity
2. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages
3. The role of the monocyte in atherogenesis, I: Transition of blood-borne monocytes into foam cells in fatty lesions
4. Oxidatively modified low-density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis
5. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition
6. Malondialdehyde alteration of low-density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages
7. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
8. Effect of dietary antioxidant combinations in humans: Protection of LDL by vitamin E but not by beta-carotene
9. Ascorbic acid oxidation product(s) protect human low-density lipoprotein against atherogenic modification: Anti-rather than prooxidant activity of vitamin C in the presence of transition metal ions
10. Antioxidant nutrient supplementation reduces the susceptibility of low-density lipoprotein to oxidation in patients with coronary artery disease
11. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
12. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits
13. Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E
14. Relation of vascular oxidative stress, alphatocopherol, and hypercholesterolemia to early atherosclerosis in hamsters
15. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
16. Hyperhomocyst(e)inemia and atherothrombosis
17. Homocystinemia: Vascular injury and arterial thrombosis
18. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
19. Promotion of vascular smooth muscle cell-growth by homocysteine: A link to atherosclerosis
20. Homocystine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis
21. Vitamin E consumption and the risk of coronary heart disease in men
22. Vitamin E consumption and the risk of coronary disease in women
23. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly
24. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
25. Vitamin C intake and mortality among a sample of the United States population
26. 6 from diet and supplements in relation to risk of coronary heart disease among women
27. Multivitamin use and mortality in a large prospective study
28. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
29. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
30. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
31. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
32. Vitamin E supplementation and cardiovascular events in high risk patients
33. Secondary Prevention With Antioxidants of Cardiovascular Disease in Endstage Renal Disease (SPACE): Randomised placebo-controlled trial
34. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction
35. Final report on the aspirin component of the ongoing Physicians' Health Study
36. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
37. Antioxidant vitamin intake and coronary mortality in a longitudinal population study
38. Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis
39. Trends in prevalence and magnitude of vitamin and mineral supplement usage and correlation with health status